4.7 Article

Synthetic studies toward Mycobacterium tuberculosis sulfolipid-I

Journal

JOURNAL OF ORGANIC CHEMISTRY
Volume 73, Issue 3, Pages 1008-1017

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jo702032c

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NIAID NIH HHS [R01 AI051622, AI51622, R01 AI051622-05, R37 AI051622] Funding Source: Medline

Ask authors/readers for more resources

[GRAPHICS] Sulfolipid-I (SL-I) is an abundant metabolite found in the cell wall of Mycobacterium tuberculosis that is comprised of a trehalose 2-sulfate core modified with four fatty acyl substituents. The correlation of its abundance with the virulence of clinical isolates suggests a role for SL-I in pathogenesis, although its biological functions remain unknown. Here we describe the synthesis of a SL-I analogue bearing unnatural lipid substituents. A key feature of the synthesis was application of an intramolecular aglycon delivery reaction to join two differentially protected glucose monomers, one prepared with a novel alpha-selective glycosylation. The route developed for the model compound can be readily extended to the synthesis of native SL-I as well as additional analogues for use in the investigation of SL-I's functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available